United Therapeutics Corporation shares owned by Winton Capital
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Winton Capital
from 13F filings
Historical chart of Winton Capital investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Winton Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Winton Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.8M | 21k | 419.21 |
| 2023-12-31 | $228k | 1.0k | 219.89 |
| 2023-09-30 | $408k | 1.8k | 225.87 |
| 2023-06-30 | $330k | 1.5k | 220.75 |
| 2023-03-31 | $2.6M | 12k | 223.96 |
| 2022-12-31 | $3.7M | 13k | 278.09 |
| 2022-09-30 | $4.0M | 19k | 209.40 |
| 2022-06-30 | $4.3M | 18k | 235.63 |
| 2022-03-31 | $2.9M | 16k | 179.39 |
| 2021-12-31 | $2.2M | 10k | 216.06 |
| 2021-09-30 | $1.6M | 8.5k | 184.55 |
| 2021-06-30 | $1.9M | 10k | 179.37 |
| 2021-03-31 | $2.2M | 13k | 167.25 |
| 2020-12-31 | $2.1M | 14k | 151.75 |
| 2020-09-30 | $3.9M | 39k | 101.01 |
| 2020-06-30 | $6.8M | 56k | 121.01 |
| 2020-03-31 | $296k | 3.1k | 94.87 |
| 2019-09-30 | $22M | 271k | 79.75 |
| 2019-06-30 | $15M | 192k | 78.06 |
| 2019-03-31 | $20M | 174k | 117.37 |
| 2018-12-31 | $17M | 159k | 108.90 |
| 2018-09-30 | $12M | 92k | 127.88 |
| 2018-06-30 | $3.8M | 33k | 113.14 |
| 2017-12-31 | $2.8M | 19k | 147.98 |
| 2017-06-30 | $8.5M | 66k | 129.74 |
| 2017-03-31 | $31M | 258k | 118.08 |
| 2016-12-31 | $26M | 178k | 143.43 |
| 2016-09-30 | $31M | 258k | 118.08 |
| 2016-06-30 | $22M | 205k | 105.92 |
| 2016-03-31 | $24M | 217k | 111.43 |
| 2015-12-31 | $25M | 157k | 156.61 |
| 2015-09-30 | $13M | 98k | 131.24 |
| 2015-06-30 | $32M | 185k | 173.95 |
| 2015-03-31 | $27M | 156k | 172.44 |
| 2014-12-31 | $14M | 109k | 129.49 |
| 2014-09-30 | $61M | 474k | 128.65 |
| 2014-06-30 | $57M | 641k | 88.49 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation